{"disease":{"id":"alk-or-ros1-positive-nsclc","name":"alk or ros1 positive nsclc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03672643","title":"Long Term Safety Observation of Crizotinib in Chinese NSCLC Population","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":41,"lead_sponsor_name":"Pfizer","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}